Companies / BOC Sciences / Sirukumab
BOC Sciences

Sirukumab | BOC Sciences

Sirukumab is a human monoclonal IgG1_ antibody that targets IL-6. Sirukumab is undergoing clinical trials for the treatment of rheumatoid arthritis (RA).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.